Dr. William Ho received his medical diploma from the University of Hawaii and completed a fellowship in medical oncology at the University of Washington. He is also a board-certified oncologist practicing at the Kaiser Permanente San Jose Medical Center. During his career, he worked on several publications in collaboration with other doctors.
University of Hawaii John A. Burns
University of Washington
American Board of Internal Medicine - Oncology
DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody-Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma.
Li, D.,Poon, K. A.,Yu, S. F.,Dere, R.,Go, M.,Lau, J.,Zheng, B.,Elkins, K.,Danilenko, D.,Kozak, K. R.,Chan, P.,Chuh, J.,Shi, X.,Nazzal, D.,Fuh, F.,McBride, J.,Ramakrish...; Mol. Cancer Ther.. 2013 Jul.See more >>
Transferred WT1-Reactive CD8+ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients.
Chapuis, A. G.,Ragnarsson, G. B.,Nguyen, H. N.,Chaney, C. N.,Pufnock, J. S.,Schmitt, T. M.,Duerkopp, N.,Roberts, I. M.,Pogosov, G. L.,Ho, W. Y.,Ochsenreither, S.,Wölfl...; Sci Transl Med. 2013 Feb 27.See more >>
Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowl...
Wolfl, M., Kuball, J., Ho, W.Y., Nguyen, H., Manley, T.J., Bleakley, M., Greenberg, P.D.; Blood. 2007 Jul 1.See more >>
Facilitating matched pairing and expression of TCR chains introduced into human T cells.
Kuball, J., Dossett, M.L., Wolfl, M., Ho, W.Y., Voss, R., Fowler, C., Greenberg, P.D.; Blood. 2007 Mar 15.See more >>